Talanx AG
LSE:0QA8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Talanx AG
LSE:0QA8
|
DE |
|
D
|
Draganfly Inc
CNSX:DPRO
|
CA |
|
N
|
NRG Energy Inc
XMUN:NRA
|
US |
|
F
|
Forte Biosciences Inc
F:37TA
|
US |
|
U
|
Universal Health Services Inc
SWB:UHS
|
US |
|
Nongfu Spring Co Ltd
F:7NF
|
CN |
Wall St Price Targets
0QA8 Price Targets Summary
Talanx AG
According to Wall Street analysts, the average 1-year price target for 0QA8 is 125.78 EUR with a low forecast of 113.19 EUR and a high forecast of 148.91 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QA8's stock price target?
Price Target
125.78
EUR
According to Wall Street analysts, the average 1-year price target for 0QA8 is 125.78 EUR with a low forecast of 113.19 EUR and a high forecast of 148.91 EUR.
What is the Revenue forecast for Talanx AG?
Projected CAGR
-3%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -3%.
What is the Net Income forecast for Talanx AG?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 5%.
